Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KEAP1 is a key regulatory protein that functions as an adaptor subunit of Cullin3-based E3 ubiquitin ligase complexes. It primarily regulates the transcription factor NRF2, promoting its degradation under normal conditions and releasing it under oxidative/electrophilic stress, leading to activation of antioxidant response element (ARE)-driven genes.
Inhibition of KEAP1 to activate NRF2
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like ECH-associated protein 1 (KEAP1).